Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

We need 'right level of reward' for services, says Boots boss

Business Multiple’s UK director of pharmacy Peter Bainbridge says sector must find the correct balance between providing free and paid-for services

Pharmacy must strike the right balance between providing free and paid-for services, Boots UK's director of pharmacy Peter Bainbridge has said.


Although some interventions were simply part of the job, pharmacists should be getting the "right level of reward" for full services, Mr Bainbridge told C+D in an exclusive interview on Monday (March 24).


Mr Bainbridge named Boots' diabetes risk assessments, launched last year, as an example of a service the multiple was happy to provide for free.


Some interventions are simply part of the job, but pharmacists should be getting the right level of reward for full services, says Boots UK's director of pharmacy Peter Bainbridge

More on Boots

Dispensing hub will not lead to redundancies, says Boots

Boots to pilot automated dispensing hub

Clinical services pilot proves pharmacy's value, says Boots director

"On something like a diabetic risk assessment, should we be recompensed for that or, actually, is it just about a pharmacist having a conversation with a patient about how they can look after their health better?" he asked. "To be honest, I don't think we should be recompensed for that because we're just doing our job."


But Mr Bainbridge stressed that Boots would push for funding if it started moving into diabetes testing and monitoring – services that it would "absolutely" consider for the future. "I think pharmacy should be paid for [those services] – especially if we can do them better, cheaper and in a more efficient way than the existing providers," he argued.


Mr Bainbridge stressed the importance of pharmacy receiving the right level of remuneration for its work. "It's [about achieving] a balance between the existing role of pharmacists and the enhanced care that role might bring, and then getting that compensation," he added.


Overall, Mr Bainbridge said that NHS commissioners were "very interested" in funding new pharmacy services if the evidence was there. But he warned that this might involve providing services free of charge at first to gather data. "Pharmacy has to really demonstrate it can do [the service], prove the outcomes and then take this to the NHS and say, ‘this is how we can help'," he said.


Earlier this month, Boots said the results of the Community Pharmacy Future project had "really demonstrated and quantified the value of pharmacy". The project, which involved pharmacies running three service pilots and gathering data on their outcomes, proved the NHS could save more than £470 million a year if it commissioned nationwide COPD and medicine support services.

What kind of services should pharmacists be paid to provide?
 
We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016913

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel